Dai, Wei Fang <br/><br/>
Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada.  [electronic resource] 

 -  BMC cancer  Apr 2020 
 - 304 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/s12885-020-06798-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Case-Control Studies<br/>Cohort Studies<br/>Databases, Pharmaceutical<br/>Female<br/>Humans<br/>Ipilimumab--administration & dosage<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Ontario<br/>Survival Analysis<br/>Treatment Outcome